Whether you have one compound or a library of compounds requiring drug metabolism assessment, Charles River can design, conduct and interpret the in vivo pharmacokinetic/ADME components of your program as part of our streamlined non-GLP screening services. Quick study initiation, multiple species, resident animal colonies (with chronic surgical models included) and various dose regimens and administration routes, plus bioanalytical support, provide the necessary tools you need to rapidly identify and optimize potential drug candidates.